AveXis, every mention
3 scenes · ← back to AveXis
tap a year for its mentions
every year anyone Vas Narasimhan 5Nate Chang 3Koki Hirasaki 1
Verbatim, from the transcripts: the passages where AveXis comes up
What’s with All the Bio M&A in 2019?: A Quick Take
- ▶ 4:23 Nate Chang Meaning, for example, Avexis and SMA, they are the, probably the leading gene therapy program out there, and they want to continue building that franchise and have not only face a patent clip, but with a new modality, they could actually… 3 times in the scene
- ▶ 8:23 Koki Hirasaki So, uh, when we met with Voss, he, he talked about, um, of access, you know, again, being a platform, but, but also giving Novartis, uh, scalable manufacturing in the gene therapy space.
a16z Podcast | The Science and Business of Innovative Medicines
- ▶ 18:32 Vas Narasimhan So if you take the example of gene therapy, we acquired a company called Avexis, though, really, I think the front leading edge gene therapy company. 5 times in the scene